Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Advisor, Clinical Pharmacology (equivalent to Associate Director) to provide technical depth in PK/PD and pharmacometrics for clinical-stage development. Reporting to the Executive Director, Clinical Pharmacology, this hands-on scientist will build, evaluate, and explain quantitative models; translate nonclinical and biomarker data into clinical decisions; and take growing ownership of clinical pharmacology deliverables within project teams. Centessa is a clinical-stage company developing orexin receptor 2 (OX2R) agonists for narcolepsy and potentially other sleep-wake disorders. Its lead investigational candidate, cleminorexton, is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. The portfolio also includes other clinical- and preclinical-stage assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions. The position contributes clinical pharmacology and PK/PD expertise to project decisions, performs and interprets pharmacokinetic and exposure–response analyses, applies PBPK models, and integrates nonclinical, in vitro ADME, and biomarker data. The role also prepares clinical and regulatory documentation, works across multidisciplinary teams, oversees CRO and vendor deliverables, and communicates findings internally and externally. The position is remote. The anticipated wage is $168,000–$268,400. Eligible full-time employees may receive a company bonus and participate in the company’s compensation and benefit programs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree